Sabah Kadri

3.9k total citations
61 papers, 1.5k citations indexed

About

Sabah Kadri is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Sabah Kadri has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 23 papers in Cancer Research and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Sabah Kadri's work include Cancer Genomics and Diagnostics (17 papers), Genomics and Rare Diseases (10 papers) and Genetic factors in colorectal cancer (9 papers). Sabah Kadri is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Genomics and Rare Diseases (10 papers) and Genetic factors in colorectal cancer (9 papers). Sabah Kadri collaborates with scholars based in United States, Israel and United Kingdom. Sabah Kadri's co-authors include Jeremy P. Segal, Panayiotis V. Benos, Veronica F. Hinman, Lauren L. Ritterhouse, Larissa V. Furtado, Chao Jie Zhen, Manuel Garber, Bradley Long, Mitchell Guttman and Y. Lynn Wang and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Sabah Kadri

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabah Kadri United States 20 677 382 233 199 195 61 1.5k
Martin Figeac France 25 645 1.0× 204 0.5× 186 0.8× 278 1.4× 203 1.0× 81 1.6k
Todd Seeley United States 12 685 1.0× 413 1.1× 202 0.9× 96 0.5× 207 1.1× 16 1.3k
Hatice Gülçin Özer United States 19 867 1.3× 363 1.0× 92 0.4× 93 0.5× 205 1.1× 61 1.6k
Sung Choe United States 20 1.1k 1.6× 345 0.9× 165 0.7× 66 0.3× 243 1.2× 48 1.8k
Stefanie S. Schalm United States 13 1.5k 2.2× 309 0.8× 387 1.7× 160 0.8× 428 2.2× 19 2.0k
Huilei Xu United States 14 1.3k 1.9× 331 0.9× 106 0.5× 73 0.4× 146 0.7× 21 1.8k
Raymond Liang United States 20 937 1.4× 229 0.6× 103 0.4× 171 0.9× 245 1.3× 50 1.8k
David Redmond United States 21 876 1.3× 241 0.6× 149 0.6× 237 1.2× 468 2.4× 59 1.9k
Samirkumar B. Amin United States 18 1.3k 1.9× 686 1.8× 256 1.1× 172 0.9× 453 2.3× 43 2.3k
Patrick R. Blackburn United States 19 923 1.4× 235 0.6× 130 0.6× 91 0.5× 250 1.3× 74 1.7k

Countries citing papers authored by Sabah Kadri

Since Specialization
Citations

This map shows the geographic impact of Sabah Kadri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabah Kadri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabah Kadri more than expected).

Fields of papers citing papers by Sabah Kadri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabah Kadri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabah Kadri. The network helps show where Sabah Kadri may publish in the future.

Co-authorship network of co-authors of Sabah Kadri

This figure shows the co-authorship network connecting the top 25 collaborators of Sabah Kadri. A scholar is included among the top collaborators of Sabah Kadri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabah Kadri. Sabah Kadri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kadri, Sabah, Kelly E. Craven, Elaine P.S. Gee, et al.. (2025). Clinical Bioinformatician Body of Knowledge—Bioinformatics and Software Core. Journal of Molecular Diagnostics. 27(7). 566–582. 2 indexed citations
2.
Rouquié, David, Andreas Bender, Jaime H. Cheah, et al.. (2025). The OASIS Consortium: integrating multi-omics technologies to transform chemical safety assessment. Toxicological Sciences. 208(2). 225–232. 1 indexed citations
3.
Petiwala, Sakina, Erin Murphy, Sabah Kadri, et al.. (2023). Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays. The CRISPR Journal. 6(1). 75–82. 2 indexed citations
4.
Duncavage, Eric J., Joshua F. Coleman, Monica E. de Baca, et al.. (2022). Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation. Journal of Molecular Diagnostics. 25(1). 3–16. 13 indexed citations
5.
Zheng, Bo, Chong Li, Shrabani Basu, et al.. (2021). The RNA structurome in the asexual blood stages of malaria pathogen plasmodium falciparum. RNA Biology. 18(12). 2480–2497. 5 indexed citations
6.
Haas, Naomi B., Leonard J. Appleman, Mark N. Stein, et al.. (2019). Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma. Clinical Cancer Research. 25(7). 2080–2087. 112 indexed citations
7.
Ritterhouse, Lauren L., Megan Parilla, Chao Jie Zhen, et al.. (2019). Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing. Molecular Diagnosis & Therapy. 23(6). 791–802. 13 indexed citations
8.
9.
10.
Ming, Mei, Wenjun Wu, Bingqing Xie, et al.. (2018). XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Molecular Cancer Therapeutics. 17(12). 2564–2574. 36 indexed citations
11.
Coffey, Greg, Jiajia Feng, Anjali Pandey, et al.. (2018). Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clinical Cancer Research. 25(4). 1174–1184. 29 indexed citations
12.
Ritterhouse, Lauren L., et al.. (2018). insiM. Journal of Molecular Diagnostics. 21(1). 19–26. 8 indexed citations
13.
Johnson, Daniel N., Larissa V. Furtado, Bradley Long, et al.. (2018). Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth. Archives of Pathology & Laboratory Medicine. 142(7). 838–850. 37 indexed citations
14.
Wang, Y. Lynn, Mei Ming, Bingqing Xie, et al.. (2017). XPO1 Inhibitor Selinexor Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma Via Nuclear Retention of IκB. Blood. 130. 3837–3837. 1 indexed citations
15.
Afik, Shaked, Osnat Bartok, Maxim N. Artyomov, et al.. (2017). Defining the 5΄ and 3΄ landscape of the Drosophila transcriptome with Exo-seq and RNaseH-seq. Nucleic Acids Research. 45(11). e95–e95. 8 indexed citations
16.
Yap, Kai Lee, Larissa V. Furtado, Kazuma Kiyotani, et al.. (2016). Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leukemia & lymphoma. 58(4). 950–958. 16 indexed citations
17.
Kadri, Sabah, Bradley Long, Chao Jie Zhen, et al.. (2016). Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays. Journal of Molecular Diagnostics. 19(1). 43–56. 106 indexed citations
18.
Engreitz, J, Amy Pandya‐Jones, Patrick McDonel, et al.. (2013). The Xist lncRNA Exploits Three-Dimensional Genome Architecture to Spread Across the X Chromosome. Science. 341(6147). 1237973–1237973. 48 indexed citations
19.
Bermano, Giovanna, Vasileios Pagmantidis, Sabah Kadri, et al.. (2007). Evidence that a polymorphism within the 3′UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes & Nutrition. 2(2). 225–232. 68 indexed citations
20.
Bermano, Giovanna, et al.. (2004). Glutathione peroxidase 4 gene polymorphism and susceptibility to colorectal cancer. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Figeac Breakdown of academic impact, for papers by Todd Seeley Breakdown of academic impact, for papers by Hatice Gülçin Özer Breakdown of academic impact, for papers by Sung Choe Breakdown of academic impact, for papers by Stefanie S. Schalm Breakdown of academic impact, for papers by Huilei Xu Breakdown of academic impact, for papers by Raymond Liang Breakdown of academic impact, for papers by David Redmond Breakdown of academic impact, for papers by Samirkumar B. Amin Breakdown of academic impact, for papers by Patrick R. Blackburn
Rankless by CCL
2026